Merck & Co Inc

NYSE: MRK
$96.31
-$2.05 (-2.1%)
Closing Price on November 15, 2024

MRK Articles

The broad markets are recovering in the wake of the Brexit and it really appears to be one big head fake. We are also realizing that the Brexit was a great opportunity to buy into the markets and...
June 29, 2016: Markets opened higher again Wednesday and every sector is again posting a gain as the closing bell approaches. A drawdown in U.S. crude oil inventories coupled with a weaker dollar...
The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through...
June 17, 2016: Markets opened lower again Friday after a somewhat disappointing report on U.S. housing starts. St. Louis Fed president James Bullard suggested that interest rate hikes may be far less...
June 16, 2016: Markets opened lower Thursday but equities showed some spunk by trading on an upward trend for nearly the whole day. Asian and European markets traded lower and economics data from the...
Merck and Afferent Pharmaceuticals reportedly have signed a definitive agreement under which the former will acquire the latter.
The May 31 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
The ASCO annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two cents on companies making presentations at the conference.
Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology (ASCO) annual meeting, and it has issued a report on what it is looking for.
May 25, 2016: Markets opened higher again Wednesday on news that eurozone ministers have agreed to release the next tranche of bailout money to Greece. The dollar weakened and crude oil prices rose...
The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
The short interest data have been released for the April 29 settlement date, and for most of the selected pharmaceutical stocks short interest decreased.
May 5, 2016: Markets opened higher on Thursday primarily on strengthening crude oil prices despite a move higher by the dollar. Higher job cuts reported by Challenger combined with a rise in new...
Drug giant Merck reported mixed first-quarter 2016 results before markets opened Thursday morning.
A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an improved formulation to a patent expiry and the opening of the floodgates for generic...